About products, innovations and the company

New PCR test to differentiate between COVID-19 and flu

EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of SARS-CoV-2, influenza virus type A and influenza virus ...

Novel ELISA for Quantification of Antibodies against S1 Protein of SARS-CoV-2

EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein.
Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and ...

INOCHEM becomes part of EUROIMMUN family

INOCHEM, S.A. DE C.V., a provider of highly specialized tests for accurate diagnostics in clinical laboratories and hospitals in the public and private segments in Mexico, is now part of EUROIMMUN. ...

EURORealTime SARS-CoV-2 approved by the FDA via an Emergency Use Authorization

Subsequent to the EUROIMMUN-Anti-SARS-CoV-2 ELISA (IgG), the EURORealTime SARS-CoV-2 for direct pathogen detection has now also been approved for use in authorised laboratories by the U.S. American ...

SARS-CoV-2 Testing from EUROIMMUN

EUROIMMUN UK, a subsidiary of EUROIMMUN AG, is based in London and has supported Public Health England (PHE) in establishing a serology assay for use in the National Testing Strategy since March with ...

FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies

WALTHAM, Mass.--(BUSINESS WIRE)--May 5, 2020-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration ...

EUROIMMUN now offers a complete test package for direct detection of the new coronavirus and antibodies against SARS-CoV-2


EUROIMMUN AG from Lübeck in Germany, a manufacturer of reagents and automated systems for medical laboratory diagnostics, has developed a PCR test for direct virus detection, in addition ...

Tests for detection of antibodies against SARS-CoV-2 now available

Press release

EUROIMMUN AG (Lübeck, Germany), a manufacturer of reagents and instruments for medical laboratory diagnostics, has developed serological tests for detection of antibodies against the ...

A new German law on mandatory measles vaccination

Recently, a new law on measles vaccination has been passed in Germany. As of March 2020, all children in Germany from the age of one year must present proof of their vaccination against measles, as ...

Fast and reliable detection of dermatomycosis pathogens

Worldwide, 20 to 25% of the population are affected by dermatomycoses. The disease manifests with reddened, scaly, burning and, particularly, itchy skin and often requires long-term treatment.

Back to top
Contact person on site
Please click on a country or enter yours
North America
South & Central America
Middle East & Africa